| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99091 |
|
1,070 |
1,024 |
$142K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,587 |
4,076 |
$130K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,360 |
1,222 |
$98K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,902 |
1,708 |
$72K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
809 |
745 |
$56K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
3,999 |
1,430 |
$34K |
| 99000 |
|
2,981 |
2,649 |
$24K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
266 |
226 |
$16K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
315 |
281 |
$13K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
192 |
175 |
$11K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
718 |
333 |
$9K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
639 |
556 |
$7K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
171 |
151 |
$7K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
116 |
94 |
$6K |
| 81003 |
|
2,826 |
2,528 |
$5K |
| 81025 |
|
826 |
732 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
206 |
181 |
$4K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
359 |
312 |
$4K |
| 94010 |
|
212 |
187 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
380 |
324 |
$3K |
| 92551 |
|
455 |
405 |
$3K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
252 |
177 |
$3K |
| 90461 |
|
435 |
288 |
$2K |
| 96160 |
|
1,384 |
1,223 |
$2K |
| 93000 |
|
153 |
132 |
$1K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
96 |
83 |
$1K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
249 |
234 |
$1K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
86 |
57 |
$576.22 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
55 |
45 |
$513.07 |
| 90619 |
|
71 |
58 |
$335.40 |
| 90715 |
|
91 |
76 |
$100.74 |
| 90658 |
|
286 |
261 |
$93.28 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
94 |
77 |
$52.85 |
| 90651 |
|
238 |
203 |
$15.27 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
48 |
38 |
$8.26 |
| 90734 |
|
97 |
88 |
$0.28 |
| 90620 |
|
141 |
119 |
$0.25 |
| 90677 |
|
12 |
12 |
$0.07 |
| 90656 |
|
18 |
18 |
$0.04 |
| 90710 |
|
17 |
14 |
$0.00 |
| 99173 |
|
593 |
498 |
$0.00 |
| 90700 |
|
89 |
78 |
$0.00 |
| 90649 |
|
16 |
16 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
117 |
106 |
$0.00 |
| 96127 |
|
753 |
614 |
$0.00 |
| 99459 |
|
42 |
36 |
$0.00 |
| 90696 |
|
16 |
14 |
$0.00 |